New research has found that the cholesterol control drug, Gemfibrozil, reduces levels of amyloid and brain inflammation in mice.

New research shows that a genetic variant of the PLCG2 gene may reduce the risk of developing some dementias and healthy ageing.

New research shows a link between reducing amyloid in the brain and slowing cognitive decline.

New research shows that a study of the immunotherapy treatment Crenezumab has found it can reduce levels of the protein amyloid, associated with dementia.

A phase 1 trial, reported in Nature Communications, has found that blood‒brain barrier (BBB) can be non-invasively and reversibly opened in five patients with Alzheimer’s disease.

New research shows that a potential new drug to treat Alzheimer’s disease, Lanabecestat, has failed a phase 2/3 trial.